Clinical Trials Browser

Observational × Carcinoma, Ductal × Clear all

NCT04985357 2024-11-25

Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs

BreastEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmThoracic

Anus Neoplasms, Appendiceal Neoplasms, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Laryngeal Neoplasms, Lip Neoplasms, Lung Neoplasms, Mesothelioma, Mouth Neoplasms, Neoplasms, Unknown Primary, Oropharyngeal Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Paranasal Sinus Neoplasms, Penile Neoplasms, Prostatic Neoplasms, Thymoma, Vulvar Neoplasms, Pleural Effusion, Malignant, Carcinoma, Neuroendocrine, Cholangiocarcinoma, Carcinoma, Ductal, Small Cell Lung Carcinoma

NCT03543397 2018-06-01

MRI in Ductal Carcinoma in Situ (DCIS)

Unknown

74 enrolled

Breast

Carcinoma, Intraductal, Noninfiltrating, Carcinoma, Ductal

NCT00132704 2014-07-24

An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation

Completed

149 enrolled

DermatologicGastrointestinalGynecologicSarcomaThoracic

Adenocarcinoma, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Leiomyosarcoma, Liposarcoma, Melanoma, Ovarian Neoplasms, Sarcoma, Colorectal Neoplasms, Endometrial Neoplasms, Carcinoma, Endometrioid, Carcinoma, Ductal, Small Cell Lung Carcinoma